🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Se...
Status
Active Not Recruiting
Location
Arkansas Diagnostic Center
Start Date
2017-12-12
Trial ID
NCT03301506
Treatments Being Tested
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with ...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-09-07
Trial ID
NCT06051617
Treatments Being Tested
The objectives of this study are to evaluate the effect of seladelpar treat...
Status
Terminated
Location
Sutter Pacific Medical Foundation - California Pacific Medical Center
Start Date
2019-11-12
Trial ID
NCT04024813
Treatments Being Tested
A Phase 2, Double-Blind (DB), Randomized, Placebo-Controlled Study Followed...
Status
Terminated
Location
CymaBay Research Site
Start Date
2018-04-30
Trial ID
NCT03551522
Treatments Being Tested
An 8-week, dose ranging, open label, randomized, Phase 2 study with a 44-we...
Status
Completed
Location
Institute for Liver Health
Start Date
2016-11-28
Trial ID
NCT02955602
Treatments Being Tested
A 52-week, placebo-controlled, randomized, Phase 3 study to evaluate the sa...
Status
Completed
Location
Institute for Liver Health
Start Date
2018-10-01
Trial ID
NCT03602560
Treatments Being Tested
The purposes of this study are to evaluate the treatment effect of seladelp...
Status
Completed
Location
The Institute for Liver Health DBA Arizona Liver Health
Start Date
2021-04-21
Trial ID
NCT04620733
Treatments Being Tested
The primary objective of this study is to evaluate the effect of seladelpar...
Status
Terminated
Location
Mayo Clinic of Arizona
Start Date
2015-11-04
Trial ID
NCT02609048
Treatments Being Tested